Evidence map›Paper›PMID 19508241›Full record

ArticleBiometrics2010

Using the optimal robust receiver operating characteristic (ROC) curve for predictive genetic tests.

Qing Lu, Nancy Obuchowski, Sungho Won, Xiaofeng Zhu, Robert C Elston

Open access · greenAbstract read
In one paragraph

Article in Biometrics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genotype-based risk and pharmacogenetic sampling in clinical trials.Journal of biopharmaceutical statistics · 2010
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Qing LuDepartment of Epidemiology, Michigan State University, East Lansing, Michigan 48823, USA.
Nancy Obuchowski
Sungho Won
Xiaofeng Zhu
Robert C Elston
Case Western Reserve University · US

Funding

X-LINKED EXTENSION OF THE REVISED HASEMAN-ELSTON ALGORITHM FOR LINKAGE ANALYSISP41RR003655 · NCRR · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI ELSTON, ROBERT C. · 1987 to 2011
$11.5M
GENETIC ANALYSIS OF MULTIFACTORIAL TRAITSR37GM028356 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI ELSTON, ROBERT C. · 1998 to 2007
$2.9M
GENETIC ANALYSIS OF MULTIFACTORIAL TRAITSR01GM028356 · NIGMS · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI ELSTON, ROBERT C. · 1985 to 1997
–
NCRR NIH HHS P41 RR003655NCRR NIH HHS RR03655NIGMS NIH HHS GM28356NIGMS NIH HHS R01 GM028356NIGMS NIH HHS R37 GM028356PHS HHS P30CAD43703Wellcome TrustWellcome Trust 076113
6 · The paper itself

Abstract

Current ongoing genome-wide association (GWA) studies represent a powerful approach to uncover common unknown genetic variants causing common complex diseases. The discovery of these genetic variants offers an important opportunity for early disease prediction, prevention, and individualized treatment. We describe here a method of combining multiple genetic variants for early disease prediction, based on the optimality theory of the likelihood ratio (LR). Such theory simply shows that the receiver operating characteristic (ROC) curve based on the LR has maximum performance at each cutoff point and that the area under the ROC curve so obtained is highest among that of all approaches. Through simulations and a real data application, we compared it with the commonly used logistic regression and classification tree approaches. The three approaches show similar performance if we know the underlying disease model. However, for most common diseases we have little prior knowledge of the disease model and in this situation the new method has an advantage over logistic regression and classification tree approaches. We applied the new method to the type 1 diabetes GWA data from the Wellcome Trust Case Control Consortium. Based on five single nucleotide polymorphisms, the test reaches medium level classification accuracy. With more genetic findings to be discovered in the future, we believe a predictive genetic test for type 1 diabetes can be successfully constructed and eventually implemented for clinical use.

Indexed as

Genetic Predisposition to DiseasePredictive Value of TestsROC CurveDiabetes Mellitus, Type 1Genetic TestingGenome-Wide Association StudyHumansLogistic ModelsPolymorphism, Single Nucleotide

Identifiers

PMID19508241
PMCPMC3039874
OpenAlexW2017211495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.